Baidu
map

我国癌痛治疗形势严峻 7成患者未受规范治疗

2015-10-26 冯会玲 央广网

据中国之声《新闻和报纸摘要》报道,我国每年新发癌症病例310多万,癌症疼痛人数将近200万,缓解疼痛最直接的办法就是使用镇痛药物,但调查显示,我国仍有70%的癌痛患者没有得到足够的止痛治疗。专家呼吁,癌痛不能靠忍耐,规范治疗不仅可以有效免除癌痛,而且能够避免药物成瘾。 原卫生部对全国范围癌痛现状调查结果显示,我国癌痛发生率为61.6%,四分之三的晚期癌症患者伴随着癌痛。中国癌症康复与姑息治疗

据中国之声《新闻和报纸摘要》报道,我国每年新发癌症病例310多万,癌症疼痛人数将近200万,缓解疼痛最直接的办法就是使用镇痛药物,但调查显示,我国仍有70%的癌痛患者没有得到足够的止痛治疗。专家呼吁,癌痛不能靠忍耐,规范治疗不仅可以有效免除癌痛,而且能够避免药物成瘾。

原卫生部对全国范围癌痛现状调查结果显示,我国癌痛发生率为61.6%,四分之三的晚期癌症患者伴随着癌痛。中国癌症康复与姑息治疗专业委员会主任委员王杰军介绍说,虽然我国1990年就开始有疼痛治疗,但仍有7成的癌痛患者没有得到足够的止痛治疗。

王杰军:我们全世界评价一个国家疼痛治疗的好坏,是根据这个国家医用吗啡的消耗量来的, 90年左右我们国家一年吗啡的消耗量大概是6公斤左右,到了13年我们国家医用吗啡的消耗量已经到了1200多公斤,尽管进步非常快,但我国癌痛治疗依然排名全世界83到85位之间,还是非常落后的。

王杰军说,包括医护人员在内,患者和患者家属都担心用镇痛类药物会成瘾,同时不少人认为癌痛是无需治疗的,而实际上,癌痛也是一种需要及时治疗的疾病。

王杰军:国际上把慢性疼痛定位为一种疾病,这个病它会影响我们的免疫系统,心理、精神,会影响病人对治疗的依从性,导致很多病人因为疼痛而自杀。

据了解,目前,我国700多家医院已经建立了疼痛规范化治疗病房,同时设立了癌痛咨询公益热线,已经为一万多人次提供服务。

王杰军:希望公众能够更好地认识疼痛是不需要忍的,而且中重度的癌痛通过口服药物就会让病人疼痛得到控制。国外也做了很多大型的很多研究来调查,会发现成瘾的比例分成低,大概在0.02%左右。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654103, encodeId=f2521654103ef, content=<a href='/topic/show?id=bcf990653d2' target=_blank style='color:#2F92EE;'>#规范治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90653, encryptionId=bcf990653d2, topicName=规范治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8e824444842, createdName=gds2017, createdTime=Wed Nov 04 05:44:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93621, encodeId=3b479362138, content=大家一起参与, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:10:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93620, encodeId=b81e9362063, content=规范从我做起, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:09:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41484, encodeId=07164148453, content=当局还是不重视医务人员的幸福感建立,没有几个人只有付出不求回报的,还是体制, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Tue Oct 27 12:45:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41463, encodeId=4dd941463e3, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Tue Oct 27 08:20:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41304, encodeId=f3e24130440, content=还是不重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Mon Oct 26 11:08:00 CST 2015, time=2015-10-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654103, encodeId=f2521654103ef, content=<a href='/topic/show?id=bcf990653d2' target=_blank style='color:#2F92EE;'>#规范治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90653, encryptionId=bcf990653d2, topicName=规范治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8e824444842, createdName=gds2017, createdTime=Wed Nov 04 05:44:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93621, encodeId=3b479362138, content=大家一起参与, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:10:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93620, encodeId=b81e9362063, content=规范从我做起, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:09:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41484, encodeId=07164148453, content=当局还是不重视医务人员的幸福感建立,没有几个人只有付出不求回报的,还是体制, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Tue Oct 27 12:45:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41463, encodeId=4dd941463e3, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Tue Oct 27 08:20:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41304, encodeId=f3e24130440, content=还是不重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Mon Oct 26 11:08:00 CST 2015, time=2015-10-26, status=1, ipAttribution=)]
    2016-07-19 doctorJiangchao

    大家一起参与

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1654103, encodeId=f2521654103ef, content=<a href='/topic/show?id=bcf990653d2' target=_blank style='color:#2F92EE;'>#规范治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90653, encryptionId=bcf990653d2, topicName=规范治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8e824444842, createdName=gds2017, createdTime=Wed Nov 04 05:44:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93621, encodeId=3b479362138, content=大家一起参与, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:10:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93620, encodeId=b81e9362063, content=规范从我做起, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:09:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41484, encodeId=07164148453, content=当局还是不重视医务人员的幸福感建立,没有几个人只有付出不求回报的,还是体制, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Tue Oct 27 12:45:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41463, encodeId=4dd941463e3, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Tue Oct 27 08:20:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41304, encodeId=f3e24130440, content=还是不重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Mon Oct 26 11:08:00 CST 2015, time=2015-10-26, status=1, ipAttribution=)]
    2016-07-19 doctorJiangchao

    规范从我做起

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1654103, encodeId=f2521654103ef, content=<a href='/topic/show?id=bcf990653d2' target=_blank style='color:#2F92EE;'>#规范治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90653, encryptionId=bcf990653d2, topicName=规范治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8e824444842, createdName=gds2017, createdTime=Wed Nov 04 05:44:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93621, encodeId=3b479362138, content=大家一起参与, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:10:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93620, encodeId=b81e9362063, content=规范从我做起, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:09:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41484, encodeId=07164148453, content=当局还是不重视医务人员的幸福感建立,没有几个人只有付出不求回报的,还是体制, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Tue Oct 27 12:45:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41463, encodeId=4dd941463e3, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Tue Oct 27 08:20:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41304, encodeId=f3e24130440, content=还是不重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Mon Oct 26 11:08:00 CST 2015, time=2015-10-26, status=1, ipAttribution=)]
    2015-10-27 三三五五

    当局还是不重视医务人员的幸福感建立,没有几个人只有付出不求回报的,还是体制

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1654103, encodeId=f2521654103ef, content=<a href='/topic/show?id=bcf990653d2' target=_blank style='color:#2F92EE;'>#规范治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90653, encryptionId=bcf990653d2, topicName=规范治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8e824444842, createdName=gds2017, createdTime=Wed Nov 04 05:44:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93621, encodeId=3b479362138, content=大家一起参与, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:10:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93620, encodeId=b81e9362063, content=规范从我做起, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:09:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41484, encodeId=07164148453, content=当局还是不重视医务人员的幸福感建立,没有几个人只有付出不求回报的,还是体制, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Tue Oct 27 12:45:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41463, encodeId=4dd941463e3, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Tue Oct 27 08:20:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41304, encodeId=f3e24130440, content=还是不重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Mon Oct 26 11:08:00 CST 2015, time=2015-10-26, status=1, ipAttribution=)]
    2015-10-27 fengzhigu

    ?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1654103, encodeId=f2521654103ef, content=<a href='/topic/show?id=bcf990653d2' target=_blank style='color:#2F92EE;'>#规范治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90653, encryptionId=bcf990653d2, topicName=规范治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8e824444842, createdName=gds2017, createdTime=Wed Nov 04 05:44:00 CST 2015, time=2015-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93621, encodeId=3b479362138, content=大家一起参与, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:10:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93620, encodeId=b81e9362063, content=规范从我做起, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Jul 19 14:09:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41484, encodeId=07164148453, content=当局还是不重视医务人员的幸福感建立,没有几个人只有付出不求回报的,还是体制, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Tue Oct 27 12:45:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41463, encodeId=4dd941463e3, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Tue Oct 27 08:20:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41304, encodeId=f3e24130440, content=还是不重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Mon Oct 26 11:08:00 CST 2015, time=2015-10-26, status=1, ipAttribution=)]
    2015-10-26 lixh1719

    还是不重视

    0

相关资讯

英国启动阿司匹林抗癌症复发试验,预计纳入1.1万人

英国开启世界上最大规模的临床试验,测试阿司匹林的抗癌效果。 据国外媒体报道,英国将启动世界上最大的临床试验测试阿司匹林的抗癌效果。大约有1.1万曾患有早期肠癌、乳腺癌、前列腺癌、胃癌以及食道癌的人们将参与这项实验。 最近几年,关于阿司匹林是否具有抗癌效果的争论由于其不确定性而越演越烈。科学家称,如果证实这种药物的效果,那么它将带来革命性变化,为癌症患者提供一种廉价而有效的治疗方

Lancet Oncol:高收入国家,本地居民患癌率与非本地居民不同

背景在高收入国家,本土居民相比非本土居民而言,往往身体素质更差,预期寿命更短暂。在澳大利亚、新西兰、加拿大和美国等国家,我们尚不清楚本地居民的癌症发病率及死亡率数据。此项研究旨在首次调查和比较在这些国家的本土人群的患癌率。 方式研究人员在澳大利亚的三个地区(昆士兰、西澳大利亚州、北领地)、新西兰,加拿大阿尔伯塔省和美国的卫生服务领域等地的肿瘤注册信息采集了人们罹患癌症的发生率。阿尔伯塔省第一民族和

J Thromb Haemost:癌症并发静脉血栓应用阿哌沙班治疗

J Thromb Haemost:癌症并发静脉血栓应用阿哌沙班治疗背景:AMPLIFY试验比较应用阿哌沙班和依诺肝素/华法林治疗急性静脉栓塞(VTE)。目的:亚组分析比较阿哌沙班和依诺肝素/华法林治疗癌症存在VTE的有效性和安全性。方法:症状性VTE患者随机分为阿哌沙班或依诺肝素/华法林治疗。主要效果预后以及安全预后分别为:VTE复发或VTE相关死亡以及严重出血。结果:共有5395名患者,其中16

JAMA Oncol:缩短预后不良的癌症患者的ICU留观时间

路透社报道称,一项新研究表明,对于一个预后不良的实体癌瘤患者来说,四天的ICU留观已经足够,血液恶性肿瘤以及一些病势稍轻的患者更适合长时间留观。这些研究结果,结合个人的偏好,将能更好地指导对于病人的临终治疗。研究人员纳入了920例危重癌症患者,比较了有时限的重症监护患者和没时限的重症监护患者30天的全因死亡率和平均生存时间。研究中发现,1-4天的留观时间对于预后不良的实体癌瘤患者已经足够,血液恶性

JAMA Oncol:癌症患者重症监护——时间多长更合适?

 就美国而言,五分之一的死亡发生在重症监护室。尽管仍不清楚更高级别的重症监护是否可以带来更好的结果,但是很难去判定病人最终是否从重症监护获益。目前被送进ICU的病人中有超过15%的是被诊断为癌症,但是恶性肿瘤的诊断是和医生的悲观有关系的。向病人提供有时间限制的重症监护是很常见的,尤其是针对恶性肿瘤患者。但是,目前鲜有证据来指导ICU监护的时间。 由此可见,确定癌症重症患者的重症

Baidu
map
Baidu
map
Baidu
map